Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASH 2018 | Naveen Pemmaraju: ‘how I Tweet’

Naveen Pemmaraju • 18 Jan 2019
ASH 2018
General

In this video, Naveen Pemmaraju, MD, of the University of Texas MD Anderson Cancer Center, Houston, TX, encourages the use of social media, particularly Twitter, for healthcare professionals to obtain vital information in the field. From the American Society of Hematology (ASH) 2018 Annual Meeting and Exposition in San Diego, CA., Dr Pemmaraju outlines the advantages of social media, including the ability to create a personal brand for your research, and connect and collaborate with key opinion leaders.

More from Naveen Pemmaraju

Evolving treatment landscape in MF: JAK inhibitors, combination therapy, and novel agents
1:39
Evolving treatment landscape in MF: JAK inhibitors, combination therapy, and novel agents
Naveen Pemmaraju • 10 Sep 2026
Exploring JAK inhibitor-based combination strategies in myelofibrosis
1:55
Exploring JAK inhibitor-based combination strategies in myelofibrosis
Naveen Pemmaraju • 10 Sep 2026
TRANSFORM-1 and navitoclax in myelofibrosis: is it time to reconsider trial endpoints?
3:03
TRANSFORM-1 and navitoclax in myelofibrosis: is it time to reconsider trial endpoints?
Naveen Pemmaraju • 10 Sep 2026
The significance of the VERIFY trial in PV: paving the way for hepcidin mimetics and modulators
1:28
The significance of the VERIFY trial in PV: paving the way for hepcidin mimetics and modulators
Naveen Pemmaraju • 10 Sep 2026

Related Videos

Key principles for implementing AI tools into clinical practice
3:19
Key principles for implementing AI tools into clinical practice
Adrián Mosquera Orgueira • 24 Sep 2026
Current role of AI in hematology/oncology: separating the hype from reality
2:54
Current role of AI in hematology/oncology: separating the hype from reality
Adrián Mosquera Orgueira • 24 Sep 2026
Addressing the risk of over-reliance on AI for clinical decision-making
2:25
Addressing the risk of over-reliance on AI for clinical decision-making
Adrián Mosquera Orgueira • 24 Sep 2026
Telomere dynamics in normal and pathological aging
12:41
Telomere dynamics in normal and pathological aging
Coleman Lindsley • 18 Sep 2026

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals